Meeting
2015 ASCO Annual Meeting
Medication use trajectories of postmenopausal breast cancer survivors and matched cancer-free controls.
Authors
Kathy Pan
Harbor-UCLA Medical Center, Torrance, CA
Kathy Pan , Rowan T. Chlebowski , Michael S. Simon , Roberta Ray , Jennifer Livaudais-Toman , Shannon D. Sullivan , Marcia L. Stefanick , Robert B. Wallace , Meryl LeBoff , Elizabeth C. Bluhm , Electra D. Paskett
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—HER2/ER
Track
Breast Cancer
Sub Track
ER+
Citation
J Clin Oncol 33, 2015 (suppl; abstr 553)
DOI
10.1200/jco.2015.33.15_suppl.553
Abstract #
553
Poster Bd #
41
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
An analysis of vitamin D (Vit D) and serum estrogens in postmenopausal (PM) breast cancer (BC) patients receiving aromatase inhibitors (AIs).
First Author: D. W. Cescon
Poster
2020 ASCO Virtual Scientific Program
Dementia risk among post-menopausal women treated with endocrine therapy for early-stage breast cancer in Ontario, Canada.
First Author: Phillip S. Blanchette
Poster
2019 Supportive Care in Oncology Symposium
Breast cancer patients in a female sexual medicine and women’s health program: A cross-sectional retrospective study.
First Author: Jeanne Carter
Poster
2017 ASCO Annual Meeting
Phase 3 randomized study of adjuvant anastrozole (A), exemestane (E), or letrozole (L) with or without tamoxifen (T) in postmenopausal women with hormone-responsive (HR) breast cancer: The FATA-GIM3 trial.
First Author: Francesco Perrone